key: cord-0880045-qt5lnnz5
authors: Lai, Angela; Chang, Megan; O’Donnell, Ryan; Zhou, Changcheng; Sumner, Jennifer A.; Hsiai, Tzung
title: Association of COVID-19 Transmission with High Levels of Ambient Pollutants: Initiation and Impact of the Inflammatory Response on Cardiopulmonary Disease
date: 2021-03-16
journal: Sci Total Environ
DOI: 10.1016/j.scitotenv.2021.146464
sha: f6cd077b605ba477a78e75d6494e55a1674fa999
doc_id: 880045
cord_uid: qt5lnnz5

Ambient air pollution contributes to 7 million premature deaths annually. Concurrently, the ongoing coronavirus disease 2019 (COVID-19) pandemic, complicated with S-protein mutations and other variants, caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in over 2.5 million deaths globally. Chronic air pollution-mediated cardiopulmonary diseases have been associated with an increased incidence of hospitalization and mechanical ventilation following COVID-19 transmission. While the underlying mechanisms responsible for this association remain elusive, air pollutant-induced vascular oxidative stress and inflammatory responses have been implicated in amplifying COVID-19-mediated cytokine release and vascular thrombosis. In addition, prolonged exposure to certain types of particulate matter (PM2.5, d < 2.5 μm) has also been correlated with increased lung epithelial and vascular endothelial expression of the angiotensin-converting enzyme-2 (ACE2) receptors to which the SARS-CoV-2 spike glycoproteins (S) bind for fusion and internalization into host cells. Emerging literature has linked high rates of SARS-CoV-2 infection to regions with elevated levels of PM2.5, suggesting that COVID-19 lockdowns have been implicated in regional reductions in air pollutant-mediated cardiopulmonary effects. Taken together, an increased incidence of SARS-CoV-2-mediated cardiopulmonary diseases seem to overlap with highly polluted regions. To this end, we will review the redox-active components of air pollutants, the pathophysiology of SARS-CoV-2 transmission, and the key oxidative mechanisms and ACE2 overexpression underlying air pollution-exacerbated SARS-CoV-2 transmission.

Despite the rising mortality rates in the highly polluted regions, the relationship between air pollutant-mediated cardiopulmonary diseases and exacerbation of COVID-19-associated comorbidities has yet to be determined (Giani et al., 2020) . High rates of hospitalization from COVID-19 outbreaks have occurred in regions with elevated levels of pollutants (Benmarhnia, 2020; Bianconi et al., 2020; Bontempi, 2020; Frontera, Martin, Vlachos, et al., 2020; Giani et al., 2020) . To further study the overlapping relationship between the impact of air pollution and COVID-19 on the cardiopulmonary system, we hereby conducted this critical review. This emerging domain of study covers the intersection of COVID-19 and the environmental impacts on the heart, lungs, and vasculature, thereby providing an epidemiological basis for future basic and clinical research. Our review highlights the inflammatory responses, and overexpression of angiotensin-converting enzyme 2 (ACE2) receptors underlying the cumulative effects of ambient PM 2.5 -exposure and SARS-CoV-2 transmission on exacerbating cardiopulmonary outcomes.

We conducted a literature search on the PubMed database for keywords ("COVID-19" OR "SARS-CoV-2") AND ("air pollution" OR "environment") AND ("cardiovascular" OR "cardiopulmonary") to identify articles that were relevant to COVID-19 and the intersection between cardiopulmonary effects and air pollution.

These articles were manually selected for further comparison. Each article was inserted into a Microsoft Excel document where the title, year, keywords, methodology, key findings, authors, and journal names were documented. Through an iterative process, J o u r n a l P r e -p r o o f the articles were coded into different themes, followed by classification into three categories in the ensuing Results section. The articles under each category were analyzed for critical reflection and future research directions.

Cumulative effects from the exposure to air pollution and COVID-19 on the cardiopulmonary system are not fully understood. From our literature search, we identified three overarching research categories that relate the cumulative effects of COVID-19 and air pollution on the cardiopulmonary systems that require future studies: (1) the direct physical impact of air pollution and COVID-19 on cardiopulmonary organs and tissues, (2) subsequent activation of immune system and imbalance in inflammatory responses, and (3) the indirect and direct effects of air pollution on the transmission of SARS-CoV-2.

3

Air pollutants and COVID-19 both enter the human body via inhalation through the lungs, and the cumulated effects may accentuate COVID-19-mediated transmission and symptoms. Patients with existing cardiopulmonary comorbidities are predisposed to cytokine storms and subsequent need for mechanical ventilation following infection (Ejaz et al., 2020; Sanyaolu et al., 2020; Vaughn et al., 2021; Silverio et al., 2021) . This may be due to the direct physical impact that both air pollution and COVID-19 impart on the cells at the respiratory interface and the cardiovascular level. The primary ingestion of air pollutant particles is through the lungs, where small gaseous air pollutants and soluble PM deposit (Rao et al., 2018) . Some atmospheric ultrafine particles (UFP, d < 0.1-0.2 μm) are reported to enter the digestive system via inhalation (Li et al., 2015) . Larger particles, including PM 10 , tend to deposit in the upper airways, whereas smaller particles, including PM 2.5 and UFP, have the potential to reach the depths of the alveolar sacs where these particles cross the alveolar epithelial and capillary endothelial tight junctions into the bloodstream (Daigle et al., 2003; Nemmar et al., 2002) . A chronic, low-grade inflammatory response due to ineffective mucociliary clearance of the particles is also implicated in the increased risk of cardiopulmonary disease (Lawal, 2017) (Table 2) .

The disease at large, COVID-19, is a respiratory infection with systemic effects.

As upper airway epithelial cells are the first to be infected, they further contribute to viral shedding and consequently, transmission, as observed during the early phase of infection, when patients' symptoms resemble a routine upper respiratory infection (Wölfel et al., 2020) .

Atmospheric pollutants, including components within PM, are well-recognized to induce a systemic inflammatory response and oxidative stress. The compositions and seasonal variations in air pollutants further modulate the overexpression of inflammatory cytokines (Kumarathasan et al., 2018) (Table 2) . A host of data supports that exposure to PM promotes cardiomyocyte injury, cardiac sodium channel dysfunction, and decreased cardiomyocyte mitochondrial function (Liu et al., 2015; Nichols et al., 2015; Wang et al., 2012) .

J o u r n a l P r e -p r o o f PM 2.5 exposure has been associated with acceleration of atherosclerosis and subsequent vascular calcification, as well as exacerbation of chronic respiratory diseases (Dominici et al., 2006; Kaufman et al., 2016; Rajagopalan et al., 2018; Sun et al., 2005) (Conticini et al., 2020) .

Due to their small size, PM 2.5 particles are widely studied epigenetic factors for cardiovascular morbidity and mortality (Kaufman et al., 2016) . Compared to PM 10 , these particles harbor a higher probability of evading the mucociliary clearance to reach the alveoli, accentuating the severity of cardiopulmonary diseases (Sun et al., 2010) . Other inhaled smaller particles, such as UFP, may further induce NF-κB-mediated vascular oxidative stress and inflammatory responses, alter the diversity of gut microbiota, and elevate circulating lipid metabolites (Li et al., 2010 (Li et al., , 2015 (Li et al., , 2017 Salim et al., 2014) ( Table 2 ).

The gaseous pollutants in the atmosphere, including nitrogen oxides (NO x ), sulfur dioxide (SO 2 ), ozone (O 3 ), carbon monoxide (CO), volatile organic compounds (VOCs), and polycyclic aromatic hydrocarbons, are considered redox-active (Manisalidis et al., J o u r n a l P r e -p r o o f 2020). Akin to PM pollution, these gaseous pollutants gain entry into the circulatory system primarily via inhalation. They can also be absorbed through the skin, causing direct damage in other organ systems (Ghorani-Azam et al., 2016) ( Table 2 ). The relatively low concentration of ambient SO 2 reacts with water to form sulfuric acid (Lipsett, 2001) . Due to hemoglobin having a higher affinity for CO rather than for oxygen, CO binds to hemoglobin upon inhalation, resulting in reduced oxygen perfusion to tissues and organs (Blumenthal, 2001) . Some VOCs such as formaldehyde and benzene are highly redox-active, undergoing photochemical reaction with other atmospheric gases. This can adversely affect the cardiopulmonary system upon inhalation. However, VOC concentrations tend to be so low that they impart little or no adversarial effects on human health ("Volatile Organic Compounds' Impact on Indoor Air Quality," 2014).

The findings in lung histology of COVID-19 patients resemble those of injured microscopic structures in air pollutant exposure. A histological study of admitted COVID-19 patients revealed viral penetration of liver and small intestine endothelial cells, as well as endothelial inflammation in the small intestine, vascular, lung, heart, liver, and kidney cells. These are all organ systems that are also affected by chronic air pollution (Varga et al., 2020) . Although preliminary, animal models exposed to chronic PM 2.5 report increased fibrosis in the alveolar walls . Current histological findings of COVID-19 patients reveal diffuse infiltration of alveolar walls by lymphocytes and edema, and patients with severe symptoms developed extensive intra-alveolar fibrin deposits in association with inflammatory or deteriorating hyaline membranes, J o u r n a l P r e -p r o o f suggestive of early onset acute respiratory distress syndrome (ARDS) (Bezzio et al., 2020) . Tissue biopsies revealed extravasation of red blood cells in both the lung and skin issues such as the mid-dermis (Jimenez-Cauhe et al., 2020; Mayor-Ibarguren et al., 2020) . Vascular injury was also a prominent feature in association with endothelial dysfunction, micro-thrombus formation, and cellular inflammation ( Figure 2 ).

Furthermore, a study in Germany found that lung histology from COVID-19 patients showed consistent diffuse alveolar injury in association with activated pneumocytes, protein-enriched edema, and microvascular thromboemboli (Wichmann et al., 2020) .

Heart tissue biopsies further revealed interstitial mononuclear inflammatory infiltrates consistent with an elevated level of serum troponin and cardiac arrhythmias; however, the molecular mechanisms remain undefined (Lindner et al., 2020) . In addition to cardiopulmonary injury, gastrointestinal involvement is reported in up to 26% of patients (Z. . These COVID-19-infected tissues run in parallel with the organ systems as reported in populations living in areas with high air pollutant concentrations.

While air pollution-mediated inflammatory effects often start in the pulmonary system, subsequent effects cascade throughout the circulatory system to induce oxidative stress and deterioration in the heart, lungs, and vasculature. In recent decades, exposure to PM 2.5 pollution has been associated with increased hospitalization and mortality, especially in patients with congestive heart failure or arrhythmia (Dominici et al., 2006; Mann et al., 2002; Pope et al., 2002) . Statistics on COVID-19 mortality corroborate that comorbidities, including coronary artery diseases, hypertension, diabetes, and congestive heart disease, worsen the severity of symptoms J o u r n a l P r e -p r o o f and patient outcomes (Harrison et al., 2020; Ssentongo et al., 2020) . In the face of increased COVID-19 cases in air pollutant-affected regions, epidemiological data supports chronic air pollution-induced oxidative stress and inflammatory response, mediating the direct impact on the cardiopulmonary system from chronic air pollution exposure.

Additionally, industrial and urban regions harbor higher PM 2.5 and PM 10 concentrations compared to rural areas. For example, rural locations in the Midwestern United States exhibited lower PM 2.5 concentrations (8.4-10.4 μg/m 3 ) as compared to urban locations (9.5-11.6 μg/m 3 ) (Kundu & Stone, 2014) . Thus, investigating the local impact of industrial areas on cardiopulmonary health is essential to elucidate the subsequent impact on the severity of COVID-19 infections. 4

Populations exposed to long-term high concentrations of PM and gaseous pollutants develop chronic inflammation in association with the pathogenesis of cardiopulmonary diseases. Similarly, a severe immune response has been reported in approximately 15% of COVID-19 patients that present with intravascular cytokine release, and, in more severe cases, microvascular thrombosis (Lippi et al., 2020) . One such response is the cytokine release syndrome (CRS) as characterized by the systemic release of cytokines, specifically, interleukin-6 (IL-6) (P. P. Hirawat et al., 2021) . The pro-thrombotic properties of cytokines promote both microvascular and macrovascular thrombosis (P. P. . In combination with raised baseline inflammation levels of populations living in areas of high air J o u r n a l P r e -p r o o f pollution concentration, the additive inflammation caused by COVID-19 further magnifies the rate of COVID-19-associated acute respiratory distress syndrome (ARDS), myocarditis, cardiac arrhythmia, and heart failure (P. P. . If left unchecked, these conditions lead to inflammatory infiltration and destruction of alveolar septae and cardiac injury, largely being responsible for patient death due to lung and heart failure (Wichmann et al., 2020) . As outlined by this section, the effects of shortand long-term exposure to air pollution create a heightened inflammatory state with symptoms that mirror those of COVID-19 patients. These consequences may be additive and exacerbate cardiopulmonary symptoms in COVID-19 patients, increasing their risk of mortality.

Effects of pollutants include pulmonary and systemic oxidative stress that alter vascular homeostasis (Roy et al., 2014) . These oxidative effects come through pollutants affecting the lipids and proteins or indirectly through the activation of intracellular oxidant pathways (Daellenbach et al., 2020; Lodovici & Bigagli, 2011) . At the molecular level, exposure to pollutants may activate cell signaling membrane receptors, intracellular phosphatases and kinases, and transcription factors that regulate inflammatory responses (Glencross et al., 2020) .

Exposure to common air pollutants is well-recognized to alter host immunity to viral respiratory infections by suppression of the host's defenses (Ciencewicki and Jaspers 2007). Long-term exposure to air pollution is linked to elevated blood pressure, ventricular diastolic dysfunction, reduced coronary flow reserve, and myocardial fibrosis J o u r n a l P r e -p r o o f (Rao et al., 2018; Wold et al., 2012) . In addition, an altered cardiac autonomic nervous system, including increased mean heart rate and heart rate variability, develop in response to prolonged exposure to air pollution (Park et al., 2005 (Park et al., , 2008 . However, short-term exposure to PM 2.5 mediates vascular endothelial dysfunction and increased blood viscosity and circulating fibrinogen to promote a hypercoagulable state, predisposing patients to hypertension, acute coronary events, heart failure, and stroke (Donaldson et al., 2001; Peters et al., 2000; Ghio et al., 2000; Nelin et al., 2012; Rajagopalan et al., 2018) . These conditions are implicated in the cumulative effects of COVID-19-patients in whom cardiac injury is evidenced by elevated serum troponin and cytokine levels in association with cardiac arrhythmia, myocarditis, and contractile dysfunction (Bonow et al., 2020; Driggin et al., 2020; Yang & Jin, 2020) .

Chronic exposure to air pollution has been associated with the expression of ACE2 in lung endothelial cells (Aztatzi-Aguilar et al., 2015; Paital & Agrawal, 2020) . ACE2 is the receptor for the SARS-CoV-2 spike protein for virus internalization into the host (Lv et al., 2020) . In mammalian models, chronic exposure to PM 2.5 has also been known to increase epithelial and endothelial ACE2 expression (Lindner et al., 2020) . In addition to binding to the ACE2 receptor, transmembrane protease serine 2 (TMPRSS2) and ACE2 is a key part of the lung renin-angiotensin system (RAS), an inflammatory response balancing act. ACE2 cleaves Angiotensin II (Ang-II) to form [Ang(1-7)] which binds to the Mas receptor. The ACE2/Ang1-7/Mas receptor axis activation is a response to PM 2.5 exposure. Mas activation occurs as a result and suppresses STAT3 and ERK, exerting an anti-inflammatory response. The other axis is the ACE/Ang-II/AT1R axis that leads to the release of proinflammatory cytokines (Chamsi-Pasha et al., 2014) . When the SARS-CoV-2 virus binds to ACE2 receptors of epithelial cells, there is an increase in Ang-II in the systemic circulation which primes the ACE/Ang-II/AT1R axis activation ( Figure 3 ). ACE2 and TMPRSS2 are ubiquitous in lung alveolar type 2 cells where their upregulation can lead to increased susceptibility to SARS-CoV-2 binding.

Atmospheric contaminants modulate the host inflammatory response, leading to overexpression of inflammatory cytokines and chemokines. The cytokine storm that is present in severely ill COVID-19 patients may also be worse in populations exposed to chronic air pollution.

The recently coined -cytokine storm‖ is a symptom seen in patients with severe COVID-19 infection and is characterized by the release of inflammatory cytokines (Hu et al., 2020; P. . Interleukin-6 (IL-6), interferon-gamma (IFN-), and tumor necrosis factor-alpha (TNF-α) are dominant cytokines released by lung epithelium upon interaction with PM (Pope et al., 2016) . When the inflammatory response -spills over‖ into systemic circulation, a cellular inflammatory response and platelet activation are implicated in the abundant microthrombi found in COVID-19 patients (Brook & Rajagopalan, 2010) . Another major route of inflammation is through the subsequent J o u r n a l P r e -p r o o f activation of the NF-κB pathway (Deng et al., 2018) . NF-κB activation after coronavirus infection occurs via pattern recognition receptors in the MyD88 pathway, resulting in cytokine induction (DeDiego et al., 2014) . Furthermore, receptor CD40, expressed by both immune and non-immune cells, binds to ligand CD40L, temporarily expressed on T cells and is involved with recruitment of TNF-α receptor-associated factors (Kawabe et al., 2011) . This interaction further leads to the release of inflammatory cytokines (Bai & Sun, 2016) . IL-6 is also a major marker of cellular senescence, supporting the notion of susceptibility to COVID-19 infection and complication from the age-dependent increase in IL-6 (Hirano & Murakami, 2020; Moccia et al., 2020) . Taken together, both ambient PM exposure and COVID-19 infection prime the host inflammatory state via the NF-κB signaling pathway in association with elevated IL-6 levels, and COVID-19 infection further potentiates the progression to cytokine storms (Kim et al., 2016) .

The precise mechanism underlying air pollution-mediated inflammation and COVID-19-mediated cardiovascular diseases remains elusive. A potential mechanism is the ACE2 receptor and disrupted activation of the RAS in the myocardium in association with the pathogenesis of cardiovascular disease (Kuba et al., 2010) . As shown by a murine model, the first generation of the SARS virus affected the pulmonary system, triggering an ACE2 dependent myocardial infarction (Kassiri et al., 2009) . Additional cellular injury due to elevated IL-6, D-dimer, ferritin, other inflammatory cytokines, and hypoxia-induced excessive intracellular calcium are also implicated in cardiac myocyte apoptosis. However, the precise mechanisms must be investigated further (Clerkin et al., 2020).

Viral entry to the host cell occurs by binding between the S1 region of the virus spike (S) protein to the ACE2 receptor on the cell surface (Lv et al., 2020) . SARS-CoV-2 binds to ACE2 for entry, and TMPRSS2 and endosomal cysteine proteases cathepsin B and L (CatB/L) prime the S protein (Hoffmann, Kleine-Weber, Schroeder, et al., 2020) .

Interestingly, SARS-CoV-2 also harbors a multibasic cleavage site at the S1/S2 boundary that is absent in SARS-CoV and other closely related animal coronaviruses (Walls et al., 2020) . This unique cleavage site can be recognized by furin, essential for

While TMPRSS2 is highly expressed in the lungs, furin is expressed in many other organs, which may contribute to SARS-CoV-2's deleterious effects on multiple organs.

In this context, developing inhibitors for both TMPRSS2 and furin may represent a promising therapeutic approach targeting SARS-CoV-2 in the setting of exposure to air pollution (Barile et al., 2020) . 5

SARS-CoV-2 is the seventh documented coronavirus to infect humans, targeting the ACE-2 receptor for entry into the host cell (Andersen et al., 2020) . While SARS-CoV-2 may not be as lethal as previous coronavirus outbreaks, its transmission rate is higher, with R 0 being between 3.6 to 4 (Chen, 2020). Respiratory viruses, including SARS-CoV-2, have been understood to undergo transmission via direct contact (person to person) and droplet (bodily fluid to person) routes (Shiu et al., 2019) . Controversy . This may point to PM 2.5 and smaller particles acting as transporters for SARS-CoV-2 particles. These PM-virus aggregates can be more easily distributed in the alveoli and upper respiratory tract and facilitate delivery and virus binding to the pulmonary epithelium (Farhangrazi et al., 2020) .

Additionally, as with other viruses, the coronaviruses have been observed to survive outside host cells for longer periods at lower temperatures and humidity (Farhangrazi et al., 2020) . However, the impact of meteorological conditions on virus transmission remains less understood. One study conducted in a tropical climate revealed that higher temperatures and increased solar radiation limited the effect on COVID-19 transmission (Rosario et al., 2020) . A similar study conducted in Italy, a Mediterranean climate, reported that temperature and humidity were negatively correlated with COVID-19 transmission (Lolli et al., 2020) . Lastly, a morecomprehensive study using spatial and temporal models found that weather had a noninfluential effect on COVID-19 transmission when compared with other factors such as J o u r n a l P r e -p r o o f homestay and urban density (Jamshidi et al., 2020) . While meteorological factors such as temperature and wind speed have been shown to potentiate the ability of coronavirus to survive outside of a host, they are unlikely to be the singular reason for the extreme variability in COVID-19 infection rates across political borders (Coccia, 2021 (Coccia, , 2021 .

The precise mechanism whereby the environment modulates SARS-CoV-2 transmission warrants further investigation. Several studies have noted the seasonal relationship between various respiratory virus infections and meteorological variables, including temperature and humidity (Moriyama et al., 2020; Srivastava, 2021) .

Furthermore, simulated sunlight deactivates SARS-CoV-2 in minutes (Schuit et al., 2020) . While PM pollution is a contributor to atmospheric haze, its impact on SARS-CoV-2 transmissibility warrants further study. Whether PM 2.5 and smaller particles have the capacity to transport SARS-CoV-2 remains to be explored. A previous outdoor study comprehensively isolated and categorized viral and microbial genetic material from PM (Cao et al., 2014) , suggesting some viral material was able to associate with the pollution particles. The three most-represented samples were DNA-based viruses; however, SARS-CoV-2 is an RNA virus, and its RNA is unstable under most extracellular conditions. Thus, whether the mere presence of viral RNA indicates infectivity also requires further validation. In addition, volcano ash emission, along with the heavy metals, may contribute to SARS-CoV-2 transmission and/or atmospheric persistence of the viral particle. Both the Po Valley and Wuhan City are relatively close to active volcanoes and vents, possibly providing a link to the severe infection and adverse clinical outcomes observed in those areas (Raciti & Calabrò, 2020) . 

Increasing evidence suggests that chronic exposure to air pollution leads to exacerbation and hospitalization of patients with COVID-19. As explained in the aforementioned redox-active mechanisms (Table 2) (Fattorini & Regoli, 2020) . The northern regions of Italy, in particular, reflected up to 80 days of exceedance per year of the regulatory limits (Fattorini & Regoli, 2020) . These same areas are regions in Italy that have experienced a high number of COVID-19 cases.

In the SARS-CoV-2 predecessors, SARS and MERS, the pre-existing cardiovascular diseases (CVDs) were reported to increase the risk of death, similar to the COVID-19 patients (Badawi & Ryoo, 2016; Booth et al., 2003; Chan et al., 2003) . In Wuhan City, where there are high levels of air pollutants, hospitalizations were significantly prevalent among the COVID-19 patients with cardiopulmonary diseases (F. . In particular, these Wuhan residents with coronary heart disease, congestive heart failure, hypertension, and/or diabetes develop increased susceptibility to the severity of COVID-19 infection and death Mutlu et al., 2007) .

Thus, patients living in polluted regions with pre-existing cardiopulmonary conditions, J o u r n a l P r e -p r o o f which may arise from exposure to air pollution, were likely to develop high rates of hospitalization when saddled with a COVID-19 infection (Hamouche et al., 2020) .

The relationship between COVID-19 and underlying cardiopulmonary diseases and impact of air pollution is an emerging topic. More studies and comprehensive reviews are necessary to further determine the interrelationships between the deleterious effects of air pollution exposure and the severity of COVID-19 infections.

This review presented overarching themes found in current literature that suggest exposure to pollution increases susceptibility to COVID-19 infection, creating a preinflammatory state in patients. Populations that are more at-risk for pollution-related CVDs, such as the elderly living in urban areas, may also be more at-risk to COVID-19 (Dockery et al., 1993) . Inhalation of PM has been associated with respiratory and cardiovascular events. Therefore, as air pollutants affect respiratory and cardiovascular health, COVID-19 prognosis and mortality are impacted by the presence of respiratory and cardiovascular comorbidities. Air pollution may also negatively impact COVID-19 outcomes.

Current literature broadly finds that chronic exposure to air pollution results in patients with higher compensatory ACE2 receptor expression, which may also lead to a lower barrier to entry for the SARS-CoV-2 virus. Targeting this pathway alongside pharmaceutical agents to reduce inflammation may ultimately mitigate the severity of symptoms in patients from areas of high air pollution. Furthermore, considering the Targeting endothelial inflammation and using anti-inflammatory drugs already proven in clinical use could be particularly relevant for vulnerable patients with preexisting endothelial dysfunction (Varga et al., 2020) . Additionally, medicine targeting ACE2 receptors may also reduce viral entry into the alveolar space. Despite concerns that CVD patients taking ACE inhibitors and angiotensin receptor blockers (ARBs) may be more-susceptible to COVID-19, due to resulting ACE2R up-regulation, a global observational study with 169 sites and 8910 patients found no increased risk of inhospital death . In addition, mitigating the long-term cardiopulmonary effects of air pollution would require concerted public health actions to J o u r n a l P r e -p r o o f help protect residents in highly polluted regions. While urban air pollution seems to have decreased in the United States during the COVID-19 pandemic, more efforts must be made to maintain lower levels even after business returns to normal (Berman & Ebisu, 2020) .

AL, RO, and MC contributed equally to this review by conducting a literature review and writing the manuscript. JAS and CZ contributed to editing. TKH conceived the review paper and edited the manuscript.

Environmental Protection Agency. https://www.epa.gov/naaqs/carbon-monoxideco-standards-risk-and-exposure-assessments-current-review and a potential therapy for the prevention and treatment of disease. PM air pollution largely targets the lung, triggering signaling pathways that have also been found to be caused by SARS-CoV-2. These signals include the release of inflammatory cytokines including IL-6, reactive oxygen species (ROS), and calcium-release activation calcium (CRAC) channels and a consequent rise in thrombotic events. Patients who already experience this response may be at risk for a higher severity of COVID-19 disease and increased risk of mortality. Figure from Menendez in Aging. 2020 under the Creative Commons license (Menendez, 2020) .

J o u r n a l P r e -p r o o f 

Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19

The Effects of Air Pollution on COVID-19 Infection and Mortality-A Review on Recent Evidence. Frontiers in Public Health

The proximal origin of SARS-CoV-2

Acute and subchronic exposure to air particulate matter induces expression of angiotensin and bradykinin-related genes in the lungs and heart: Angiotensin-II type-I receptor as a molecular target of particulate matter exposure

Prevalence of Diabetes in the 2009 Influenza A (H1N1) and the Middle East Respiratory Syndrome Coronavirus: A Systematic Review and Meta-Analysis

Fine particulate matter air pollution and atherosclerosis: Mechanistic insights

Potential Therapeutic Targeting of Coronavirus Spike Glycoprotein Priming

Basic Information about NO2

Linkages Between Air Pollution and the Health Burden From COVID-19: Methodological Challenges and Opportunities

Changes in U.S. air pollution during the COVID-19 pandemic

Outcomes of COVID-19 in 79 patients with IBD in Italy: An IG-IBD study

Particulate matter pollution and the COVID-19 outbreak: Results from

Italian regions and provinces

Air pollution and cardiovascular disease: A statement for healthcare professionals from the Expert Panel on Population and Prevention Science of the

Particulate matter air pollution and atherosclerosis

Pulmonary pathology and COVID-19: Lessons from autopsy. The experience of European Pulmonary Pathologists

Inhalable microorganisms in Beijing's PM2.5 and PM10 pollutants during a severe smog event

United States J o u r n a l P r e -p r o o f and Mortality

Can atmospheric pollution be considered a co-factor in extremely high level of SARS-CoV-2 lethality in Northern Italy? Environmental Pollution

Coronavirus disease (COVID-19)

Sources of particulate-matter air pollution and its oxidative potential in Europe

Ultrafine particle deposition in humans during rest and exercise

Management of IBD during the COVID-19 outbreak: Resetting clinical priorities

Coronavirus virulence genes with main focus on SARS-CoV envelope gene

Suppression of NF-κB Activity: A Viral Immune Evasion Mechanism

An association between air pollution and mortality in six U

Fine Particulate Air Pollution and Hospital Admission for Cardiovascular and Respiratory Diseases

Ambient particle inhalation and the cardiovascular system: Potential mechanisms. Environmental Health Systems During the COVID-19 Pandemic

COVID-19 and comorbidities: Deleterious impact on infected patients

Airborne Particulate Matter and SARS-CoV-2 Partnership: Virus Hitchhiking, Stabilization and Immune Cell Targeting -A Hypothesis

Role of the chronic air pollution levels in the Covid-19 outbreak risk in Italy

Severe air pollution links to higher mortality in COVID-19 patients: The -double-hit‖ hypothesis

Regional air pollution persistence links to COVID-19 infection zoning

Concentrated ambient air particles induce mild pulmonary inflammation in healthy human volunteers

Effects of air pollution on human health and practical measures for prevention in Iran

Short-term and long-term health impacts of air pollution reductions from COVID-19 lockdowns in China and Europe: A modelling study

Air pollution and its effects on the immune system

Ambient Pollution and Heart Rate Variability

United States Environmental Protection Agency

Pathophysiology and pharmacological management of pulmonary and cardiovascular features of COVID-19

Advance online publication

Decrease in Ambient Fine Particulate Matter during COVID-19 Crisis and Corresponding Health Benefits in Seoul

Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis

Policy implications for countries in eastern Europe

COVID-19: A New Virus, but a Familiar Receptor and Cytokine Release Syndrome

Targeting inflammatory cytokine storm to fight against COVID-19 associated severe complications

The association between air pollution and heart failure, arrhythmia, embolism, thrombosis

Effects of air pollution on blood pressure: A population-based approach

Inhalable Particulate Matter and Health (PM2.5 and PM10). (n.d.). Retrieved

Global to USA County Scale Analysis of Weather, Urban Density, Mobility, Homestay, and Mask Use on COVID-19

Elevated Plasmin(ogen) as a Common Risk Factor for COVID-19 Susceptibility

Effect of ambient air pollutants and meteorological variables on COVID-19 incidence

Erythema multiforme-like eruption in patients with COVID-19 infection: Clinical and histological findings

Association between air pollution and coronary artery calcification within six metropolitan areas in the USA (the Multi-Ethnic Study of Atherosclerosis and Air Pollution): A longitudinal cohort study

CD40/CD40 ligand interactions in immune responses and pulmonary immunity

Diesel Exhaust Particles Upregulate Interleukins IL-6 and IL-8 in Nasal Fibroblasts

Trilogy of ACE2: A peptidase in the renin-angiotensin system, a SARS receptor, and a partner for amino acid transporters

Cardiovascular and inflammatory mechanisms in healthy humans exposed to air pollution in the vicinity of a steel mill

Composition and sources of fine particulate matter across urban and rural sites in the Midwestern United States

Air particulate matter induced oxidative stress and inflammation in cardiovascular disease and atherosclerosis: The role of Nrf2 and AhR-mediated pathways

Effect of Exposure to Atmospheric Ultrafine Particles on Production of Free Fatty Acids and Lipid Metabolites in the Mouse Small Intestine

Ultrafine particles from diesel vehicle emissions at different driving cycles induce differential vascular pro-inflammatory responses: Implication of chemical components and NF-κB signaling

Ambient Ultrafine Particle Ingestion Alters Gut Microbiota in Association with Increased Atherogenic Lipid Metabolites

Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases

COVID-19: Unravelling the clinical progression of nature's virtually perfect biological weapon

Ozone

Potential secondary transmission of SARS-CoV-2 via wastewater. The Science of the Total Environment

The Science Underlying COVID-19: Implications for the Cardiovascular System

Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals

Air pollution and adverse cardiac remodeling: Clinical effects and basic mechanisms

Oxidative stress and air pollution exposure

Impact of meteorological conditions and air pollution on COVID-19 pandemic transmission in Italy

Diesel exhaust inhalation increases thrombus formation in man

Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody

Environmental and Health Impacts of Air Pollution: A Review. Frontiers in Public Health

Air pollution and hospital admissions for ischemic heart disease in persons with congestive heart failure or arrhythmia

Air Pollution and the Novel Covid-19 Disease: A Putative Disease Risk Factor

Cutaneous small vessel vasculitis secondary to COVID-19 infection: A case report

COVID-19 Illness and Heart Failure: A Missing Link?

Metformin and SARS-CoV-2: Mechanistic lessons on air pollution to weather the cytokine/thrombotic storm in COVID-19

Obesity and COVID-19: What makes obese host so vulnerable?

Ambient nano and ultrafine particles from motor vehicle emissions: Characteristics, ambient processing and implications on human exposure

Seasonality of Respiratory Viral Infections

Present cum future of SARS-CoV-2 virus and its associated control of virus-laden air pollutants leading to potential environmental threat -A global review

Ambient particulate matter accelerates coagulation via an IL-6

United States Environmental Protection Agency

Direct and indirect effects of particulate matter on the cardiovascular system

Passage of inhaled particles into the blood circulation in humans

Air Pollution Scenario over China during COVID-19

Cardiac and mitochondrial dysfunction following acute pulmonary exposure to mountaintop removal mining particulate matter

Air pollution by NO2 and PM2.5 explains COVID-19 infection severity by overexpression of angiotensin-converting enzyme 2 in J o u r n a l P r e -p r o o f respiratory cells: A review

Concentrations and co-occurrence correlations of 88 volatile organic compounds (VOCs) in the ambient air of 13 semi-rural to urban locations in the United States

Effects of air pollution on heart rate variability: The VA normative aging study

Air pollution and heart rate variability: Effect modification by chronic lead exposure

Particulate air pollution is associated with an acute phase response in men

Air pollution and cardiac arrhythmia

Hazardous air pollutant exposure as a contributing factor to COVID-19 mortality in the United States

Exposure to Fine Particulate Air Pollution Is Associated With Endothelial Injury and Systemic Inflammation

Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution

Can volcanic trace elements facilitate Covid-19 diffusion? A hypothesis stemming from the Mount Etna area

Air Pollution and Cardiovascular Disease

Effect of Particulate Matter Air Pollution on Cardiovascular Oxidative Stress Pathways

Dexamethasone in Hospitalized Patients with Covid-19-Preliminary Report

COVID-19 and Italy: What next? The Lancet

Relationship between COVID-19 and weather: Case study in a tropical country

The Cardiopulmonary Effects of Ambient Air Pollution and Mechanistic Pathways: A Comparative Hierarchical Pathway Analysis

Type 2 and interferon inflammation

Air pollution effects on the gut microbiota: A link between exposure and inflammatory disease

Comorbidity and its Impact on Patients with COVID-19

Airborne SARS-CoV-2 Is Rapidly Inactivated by Simulated Sunlight

Controversy around airborne versus droplet transmission of respiratory viruses: Implication for infection prevention

Cardiovascular risk factors and mortality in hospitalized patients with COVID-19: Systematic review J o u r n a l P r e -p r o o f and meta-analysis of 45 studies and 18,300 patients

COVID-19 and air pollution and meteorology-an intricate relationship: A review

Association of cardiovascular disease and 10 other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis

Sulfur Dioxide (SO2) Pollution

United States Environmental Protection Agency

Cardiovascular effects of ambient particulate air pollution exposure

Long-term air pollution exposure and acceleration of atherosclerosis and vascular inflammation in an animal model

Particulate air pollution induces progression of atherosclerosis

Integrated Science Assessment (ISA) for Particulate Matter (Final Report

Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1

Endothelial cell infection and endotheliitis in COVID-19

A review of the main histopathological findings in coronavirus disease 2019

Relationship of socio-demographics, comorbidities, symptoms and healthcare access with early COVID-19 presentation and disease severity

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in

Particulate matter induces cardiac arrhythmias via dysregulation of carotid body sensitivity and cardiac sodium channels

Particulate Air Pollution and the Rate of Hospitalization for Congestive Heart Failure among

Medicare Beneficiaries in

Autopsy Findings and Venous Thromboembolism in Patients With COVID-19

Cardiovascular Remodeling in Response to Long-Term Exposure to Fine Particulate Matter Air Pollution

Virological assessment of hospitalized patients with COVID-2019

A new coronavirus in China

Exposure to air pollution and COVID-19 mortality in the United States: A nationwide crosssectional study

Impact of the COVID-19 Event on Air Quality in Central China

An Acute Respiratory Infection Runs Into the Most Common Noncommunicable Epidemic-COVID-19 and Cardiovascular Diseases

The Effect of Particulate Air Pollution on Emergency Admissions for Myocardial Infarction: A Multicity Case-Crossover Analysis

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Effect of Gastrointestinal Symptoms in Patients With COVID-19

The present work was funded by AHA COVID-19 Rapid Response (TKH), NIH grants 

PM2.5 combustion sources (e.g. vehicle emissions and industrial processes) natural causes (e.g. wildfires) atmospheric photochemical reactions with gaseous pollutants such as NOx, O3, SO2, CO, and VOCs Only the most representative citations are given. PM, particulate matter (PM2.5, particles with a diameter ≤ 2.5 μm; PM10, particles with a diameter ≤ 10 μm; PM0.1, particles with a diameter ≤ 2.5 μm; NO2, nitrogen dioxide; NOx, nitrogen oxides; O3, ozone; CO, carbon monoxide; SO2, sulfur dioxide; VOC, volatile organic compounds; μg /m 3 , micrograms per meter cubed; ppm, parts per million; CVD, cardiovascular disease; ROS, reactive oxygen species; CRP, C-reactive protein J o u r n a l P r e -p r o o f

☒ The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.☐The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: J o u r n a l P r e -p r o o f